Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Omega-3 polyunsaturated Fatty Acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation.

Indian pacing and electrophysiology journal

Patel D, Shaheen M, Venkatraman P, Armaganijan L, Sanchez JE, Horton RP, Di Biase L, Mohanty P, Canby R, Bailey SM, Burkhardt JD, Gallinghouse GJ, Zagrodzky JD, Kozeluhova M, Natale A.
PMID: 19898653
Indian Pacing Electrophysiol J. 2009 Nov 01;9(6):292-8.

OBJECTIVE: To assess if patients treated with omega-3(n-3) polyunsaturated fatty acids (PUFAS) had lower procedural failure rates compared to an untreated population.METHODS AND RESULTS: From January 2004 to 2007, 1500 PVAI patients underwent catheter ablation. Two hundred and eighty...

Stroke prevention in atrial fibrillation: latest clinical trials and guidelines.

Pharmaceuticals (Basel, Switzerland)

Armaganijan L, Patel D, Dietrich C, Morillo CA.
PMID: 24281408
Pharmaceuticals (Basel). 2012 Apr 05;5(4):384-97. doi: 10.3390/ph5040384.

Atrial Fibrillation (AF) is the most common sustained arrhythmia and 1/6 strokes is attributed to AF. The cornerstone of treatment remains maintaining sinus rhythm or appropriate ventricular rate control in addition to prevention of stroke. Oral anticoagulation therapy (OAC)...

A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link.

Cardiovascular psychiatry and neurology

Patel D, Mc Conkey ND, Sohaney R, Mc Neil A, Jedrzejczyk A, Armaganijan L.
PMID: 23710335
Cardiovasc Psychiatry Neurol. 2013;2013:159850. doi: 10.1155/2013/159850. Epub 2013 Apr 27.

Atrial fibrillation (AF) is the most commonly seen arrhythmia in clinical practice. At present, few studies have been conducted centering on depression and anxiety in AF patients. Our aim in this systematic review is to use the relevant literature...

Treatment of vasovagal syncope: an update.

Current treatment options in cardiovascular medicine

Armaganijan L, Morillo CA.
PMID: 20842568
Curr Treat Options Cardiovasc Med. 2010 Oct;12(5):472-88. doi: 10.1007/s11936-010-0087-4.

OPINION STATEMENT: Vasovagal syncope (VVS) remains the most common cause of syncope and transient loss of consciousness in all age groups. The treatment of VVS focuses on measures that interrupt or prevent its pathophysiologic mechanism, as well as on...

Showing 1 to 4 of 4 entries